Valuation : Anpario plc

Market Cap 108M 147M 126M 118M 202M 13.85B 204M 1.4B 545M 7.08B 550M 538M 22.79B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 93.68M 127M 109M 102M 175M 11.99B 176M 1.21B 472M 6.13B 476M 466M 19.73B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.68x
Free-Float
71.2%
Yield 2026 *
2.49%
Yield 2027 * 2.57%
1 week+1.90%
Current month-0.19%
1 month+0.94%
3 months-1.83%
6 months+9.18%
Current year+12.63%
1 week 520
Extreme 520
540
1 month 500
Extreme 500
540
Current year 391.11
Extreme 391.11
580
1 year 391.11
Extreme 391.11
580
3 years 200
Extreme 200
580
5 years 177
Extreme 177
710
10 years 177
Extreme 177
729.6
Manager TitleAgeSince
Chief Executive Officer 61 13/01/2016
Director of Finance/CFO - 01/07/2021
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 01/12/2006
Director/Board Member 66 01/10/2009
Chairman 67 29/06/2023
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/25 A Buy

Chief Financial Officer

3,778 0.0185%
4/2/25 A Buy

Chief Financial Officer

5,010 0.0245%
4/2/25 A Sell

Chief Financial Officer

7,621 0.0373%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.90%+30.49%+151.76% 146M
-4.77%-2.89%-26.52%-7.61% 11.31B
-0.85%-0.99%-27.08%-40.17% 4.7B
+8.25%+8.61%-25.96%-36.00% 2.81B
-1.15%+1.58%+31.35%+52.07% 2.73B
-1.80%-1.80%-21.58%-49.92% 2.12B
-3.83%+1.01%-34.14%-65.52% 1.27B
-0.77%-5.76%+18.57%+81.74% 1.16B
-1.23%+9.23%-20.23%-21.99% 856M
-9.54%-8.86%-3.69%-15.51% 837M
Average -1.57%-0.67%-7.88%+4.89% 2.79B
Weighted average by Cap. -2.02%-1.83%-17.83%-12.09%

Financials

2026 *2027 *
Net sales 50.35M 68.15M 58.64M 55.03M 93.97M 6.44B 94.71M 651M 254M 3.29B 256M 250M 10.6B 52.52M 71.09M 61.17M 57.4M 98.02M 6.72B 98.8M 679M 264M 3.43B 267M 261M 11.06B
Net income - -
Net Debt -14.55M -19.69M -16.94M -15.9M -27.15M -1.86B -27.37M -188M -73.25M -951M -73.95M -72.34M -3.06B -20.04M -27.13M -23.34M -21.9M -37.4M -2.56B -37.7M -259M -101M -1.31B -102M -99.65M -4.22B
Logo Anpario plc
Anpario plc is a United Kingdom-based independent manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity. The Company’s addictive solutions include poultry, ruminant, swine, aqua and feed mill. Its product categories include health & performance, toxin management, feed quality, and hygiene & insect control. Its health & performance products include Orego-Stim Range, Orego-Stim Range (Aqua), pHorce Range, Salkil Range, Optomega Range and Genex Range. Its toxin management products include Anpro Range and Anpro Advance. Its feed quality products include pHorce Range, Salgard Range, Mastercube Range, Moldgard, Oxigard Range and Feedzyme Range. Its technologies are sold in over 80 countries through established sales and distribution networks, which include a number of wholly owned subsidiaries.
Employees
162
Date Price Change Volume
03/09/26 GBX 535.00 0.00% 11,018
02/09/26 GBX 535.00 0.00% 3,718
01/09/26 GBX 535.00 -0.19% 38,571
28/08/26 GBX 536.00 +2.10% 72,501
27/08/26 GBX 525.00 +0.96% 3,966
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.350GBP
Average target price
5.980GBP
Spread / Average Target
+11.78%

Net sales - Rate of surprise